MAPT and Alzheimer disease: Tau aggregates composed of the microtubule binding region (MTBR) of tau are significantly associated with the clinical and cognitive symptoms of AD, and the MTBR of tau containing the residue 243 (MTBR-tau243) emerged as a novel specific AD biomarker in both CSF and plasma.